1. Home
  2. CNO vs AMRX Comparison

CNO vs AMRX Comparison

Compare CNO & AMRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CNO
  • AMRX
  • Stock Information
  • Founded
  • CNO 1979
  • AMRX 2002
  • Country
  • CNO United States
  • AMRX United States
  • Employees
  • CNO N/A
  • AMRX N/A
  • Industry
  • CNO Accident &Health Insurance
  • AMRX Biotechnology: Pharmaceutical Preparations
  • Sector
  • CNO Finance
  • AMRX Health Care
  • Exchange
  • CNO Nasdaq
  • AMRX Nasdaq
  • Market Cap
  • CNO 3.6B
  • AMRX 2.9B
  • IPO Year
  • CNO 1987
  • AMRX N/A
  • Fundamental
  • Price
  • CNO $39.77
  • AMRX $9.62
  • Analyst Decision
  • CNO Hold
  • AMRX Strong Buy
  • Analyst Count
  • CNO 5
  • AMRX 4
  • Target Price
  • CNO $43.40
  • AMRX $11.50
  • AVG Volume (30 Days)
  • CNO 612.6K
  • AMRX 1.6M
  • Earning Date
  • CNO 10-30-2025
  • AMRX 08-05-2025
  • Dividend Yield
  • CNO 1.71%
  • AMRX N/A
  • EPS Growth
  • CNO N/A
  • AMRX N/A
  • EPS
  • CNO 2.77
  • AMRX 0.01
  • Revenue
  • CNO $4,382,400,000.00
  • AMRX $2,852,914,000.00
  • Revenue This Year
  • CNO N/A
  • AMRX $9.56
  • Revenue Next Year
  • CNO $3.21
  • AMRX $6.27
  • P/E Ratio
  • CNO $14.36
  • AMRX $884.41
  • Revenue Growth
  • CNO 0.96
  • AMRX 9.81
  • 52 Week Low
  • CNO $31.40
  • AMRX $6.69
  • 52 Week High
  • CNO $43.20
  • AMRX $9.79
  • Technical
  • Relative Strength Index (RSI)
  • CNO 59.63
  • AMRX 68.88
  • Support Level
  • CNO $38.66
  • AMRX $9.32
  • Resistance Level
  • CNO $39.82
  • AMRX $9.76
  • Average True Range (ATR)
  • CNO 0.67
  • AMRX 0.22
  • MACD
  • CNO 0.12
  • AMRX -0.02
  • Stochastic Oscillator
  • CNO 72.66
  • AMRX 71.19

About CNO CNO Financial Group Inc.

CNO Financial Group Inc is a holding company for a group of insurance companies that offers middle-income American consumers insurance and securities products through exclusive agents, independent producers, and direct marketing. Consumers are served through the phone, online, mail, face-to-face with agents, or sales channels. The company's operating segments include annuity, health, and life insurance product lines as well as the investment and fee revenue segments. Maximum revenue is generated from the health product line segment. Annuity premiums account for the majority of the total premiums collected. Annuity products include fixed index annuities, traditional fixed-rate annuities, and single-premium immediate annuity products.

About AMRX Amneal Pharmaceuticals Inc.

Amneal Pharmaceuticals Inc is a pharmaceutical company operating in the U.S., India, and Ireland. With three reportable segments; Affordable Medicines, Specialty, and AvKARE - It develops, manufactures, and distributes a diverse portfolio of essential medicines. The Affordable Medicines segment focuses on a wide range of dosage forms and delivery systems, contributing significantly to revenues. The Specialty segment promotes proprietary branded pharmaceuticals, particularly targeting the central nervous system and endocrine disorders. The AvKARE segment provides pharmaceuticals and medical products to governmental agencies, specializing in re-packaging and wholesale distribution, with a focus on offering consistent care and pricing to qualified entities.

Share on Social Networks: